Alpine Associates Management’s Acceleron Pharma XLRN Stock Holding History

Alpine Associates Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-354,300	Closed	-$61M	–	63
2021 Q3	$61M	Buy	+354,300	New	+$46.3M	1.98%	17

Alpine Associates Management's XLRN Position: Q4 2021 in Review

Alpine Associates Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 354,300 shares — an estimated $61M sold.

Alpine Associates Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $61M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Alpine Associates Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Alpine Associates Management sold 354,300 Acceleron Pharma shares in Q4 2021, an estimated $61M.
Alpine Associates Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Alpine Associates Management's Acceleron Pharma position peaked at $61M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Alpine Associates Management's 13F filing for Q4 2021, filed 8 Feb 2022.